We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (247)
- Medicines safety (149)
- COVID-19 (144)
- Prescription medicines (131)
- Regulatory compliance (123)
- COVID-19 vaccines (88)
- Legislation (81)
- Therapeutic goods regulation (71)
- Listed medicines (50)
- Non-prescription medicines (46)
- Safety (44)
- Medical devices safety (43)
- Vaping hub (35)
- Complementary medicines (31)
- Manufacturing (30)
- Labelling and packaging (28)
- Assessed listed medicines (24)
- Over the counter (OTC) medicines (24)
- Scheduling (national classification system) (24)
- Compliance and enforcement hub (22)
- Medicinal cannabis hub (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (18)
- Alert/Advisory (14)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Registered complementary medicines (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1066 result(s) found, displaying 126 to 150
-
Media releasesTGA has accepted a court enforceable undertaking from Yossef Wahib, operator of the online store Aussie Mega Supplements. Mr Wahib was also issued an infringement notice for $3,756.
-
Compliance undertakingsThe TGA has accepted a court enforceable undertaking from Yossef Wahib, operator of the online store Aussie Mega Supplements, in relation to alleged illegal manufacture, supply and advertising of unregistered therapeutic goods.
-
Media releasesWe have issued infringement notices for $13,656 to 2 registered nurses for allegedly importing unapproved cosmetic injectables and advertising prescription-only medicines.
-
Media releasesIf your business is involved with medicinal cannabis, read our updated guidance about advertising medicinal cannabis to consumers.
-
Media releasesFrom 1 January 2024, the importation of disposable vapes will be prohibited, subject to very limited exceptions. Read more about the first stage of Australia’s vaping reforms.
-
NoticesWe have issued a notice to Pracmed Healthcare Pty Ltd to cease advertising indications related to weight loss surgery and cognitive function.
-
BlogThere has been a lot of discussion about sunscreen recently. All sunscreens that have a primary purpose of protecting against UV radiation are regulated by the TGA. They must be included in the Australian Register of Therapeutic Goods (ARTG) to be lawfully supplied in Australia
-
NewsWe are advising sponsors, who are intending to register new prescription medicines, of a new way to pursue work-sharing for priority applications.
-
NoticesWe've created a new GMP clearance Sponsor Information Dashboard (SID) to provide industry with current information about our processing times, workload and key messages. We have also updated our GMP clearance guidance.
-
NoticesFind out about how GMP clearances for manufacturing sites in Bulgaria can now be assessed via the Mutual Recognition Agreement (MRA) pathway.
-
NoticesInformation about GMP clearances issued via the MRA Pathway that expire on 31 December 2023 as well as information on the ongoing use of the GMP clearance questionnaire.
-
Safety updatesBe alert to new warnings of romosozumab (Evenity) cardiovascular risks for patients with a history of heart attack or stroke. If you're a health professional, read our Medicine safety update.
-
Media releasesIf you use a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine you may be affected by this recall action. Register your machine for repair or replacement to avoid any potential risks.
-
BlogIf you create content, you should know how to protect yourself and your business when it comes to promoting therapeutic goods.
-
Media releasesWe have alleged that the advertising on the company's website and social media was unlawful because medicinal cannabis products are prescription-only medicines that can't be advertised directly to consumers.
-
Media releasesThe changes will help address the significant public health issues caused by vaping in Australia, while keeping legitimate patient access to therapeutic vapes.
-
BlogIf you have ever taken medicines, received an implant, had a blood transfusion or been given a vaccine, the TGA regulates those products. Did you know that the TGA also regulates some common products you’ll find in your local supermarket or health store?
-
NewsWe have launched a new search feature in the Adverse Event Management System (AEMS) portal. As a sponsor, you can access adverse event reports about your medicines and biologicals.
-
Safety updatesIf you're a health professional, get the latest information about medicines with safety related updates to their Product Information.
-
Media releasesWe've worked with the Australian Border Force to keep more than 307,000 units of unlawfully imported medicines and medical devices out of the Australian market.
-
Media releasesWe have issued 45 infringement notices totalling $742,500 to InstantScripts Pty Ltd for the alleged unlawful advertising of prescription-only medicines.
-
NewsIt's #MedSafetyWeek, a global movement to encourage the reporting of medicine side effects (known as ‘adverse events’). You can join in and help spread the word.
-
COVID-19 vaccine safety reportsIn line with the official end of the COVID-19 emergency response, this will be our last regular COVID-19 Vaccine Safety Report. We will continue safety monitoring of COVID-19 vaccines.
-
NoticesWe've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
-
Media releasesThe Federal Court of Australia has ordered Vapor Kings Pty Ltd to pay $4.9 million for unlawfully advertising nicotine vaping products. A company Director was also ordered to pay $100,000 in penalties.